02/24/2024 09:04:40
  • Home | The Scottish Uprising
  • In this issue
  • NSF
  • Contents
  • Daiichi Jitsugyo
  • News
  • Hapa Company Insight
  • Bioadvice
  • The pharma industry briefing
  • Komtur Pharmaceuticals Company Insight
  • Komtur Pharmaceuticals
  • Where is the UK’s supply of Migraleve?
  • AtoZ-CRO GmbH Company Insight
  • AtoZ-CRO GmbH
  • Drugs from corn? Harvesting Mirexus’ phytoglycogen nano-particle
  • Phoenix Group Company Insight
  • Phoenix Group
  • Castleman disease: does machine learning hold the key to better treatment?
  • Capsugel Company Insight
  • Callery
  • A health check for Scotland’s pharmaceutical industry
  • ImmuMap Company Insight
  • ImmuMap
  • Moderna’s gamble: what’s behind biotech’s biggest-ever IPO?
  • Centaur Clinical | Company Insight
  • Centaur Clinical
  • DelSiTech: leveraging silica’s properties to improve drug delivery
  • Alpex Pharma
  • Albypharma
  • ‘Gene genie’: can CRISPR/Cas9 deliver on its promise to transform genome therapy?
  • Zenatek
  • Events
  • Sanofi
  • Event: CPhl Japan
  • Pfanstiehl
  • Next issue
02/20/2019 00:00:00